Dung “Zung” Thai, M.D., Ph.D.

Dr. Zung Thai joined Biotheryx as Chief Medical Officer in January 2020. He has held leadership roles at small and large biopharmaceutical companies, including Amgen, Gilead Sciences, Atara, Arresto, Anza and REMD Biotherapeutics, where he led the development of small molecule and protein therapeutics in metabolism, oncology and fibrotic diseases. Dr. Thai earned an A.B. from Cornell University and M.D./Ph.D. in pharmacology from the University of Pittsburgh School of Medicine. He was a fellow and clinical instructor in the department of clinical pharmacology at University of California, San Francisco, and a post-doctoral fellow at the University of California, Berkeley and Carnegie Mellon University.